Biogen Inc. Global Phase 3 Overlap Study Evaluates the Efficacy and Safety of Ferzaltamab compared to placebo in adults with delayed AMR AMR is the main cause of kidney transplant …
Tag:
AntibodyMediated
-
Kidney Transplantation
-
Kidney Transplantation
HI-Bio Announces Positive Results from Phase 2 Study of Felzalutamab for Late Antibody-Mediated Rejection in Kidney Transplant Patients
by HI-Bioby HI-Bio82% (n=9/11) of patients who received felzaltamab experienced resolution of symptoms. Antibody-mediated rejection The proportion of patients meeting the Banff criteria in the 24-week biopsy was significantly increased compared to …